Gene Bridges licenses Red/ET Recombineering to Genencor
Under the terms of the agreement, Gene Bridges has licensed the Red/ET technology to Genencor for the purpose of genetically engineering recombinant micro-organisms for use in industrial applications. No financial details were disclosed.
Gary Stevens, CEO of Gene Bridges GmbH, commented: "We are very pleased to add Danisco to the list of major industrial biotechnology companies using Red/ET. Recombineering is the technology of choice in DNA engineering and is used worldwide in industry and academia."
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.